I completed my bachelor's degree in Bio-pharmaceutical Sciences and my master's in Biomedical Sciences. During my studies, I developed a strong interest in immunology. I explored this interest with an internship at the department of Experimental Hematology at the LUMC investigating cross-reactivity of SARS-CoV-2 specific T cells. During my time in this department, I became intrigued by immunotherapy research. My fascination for the diversity of T cells and their potential to be used as immunotherapy led me to pursue a PhD in Dr. Amanda Foks' Aging and Immunity group. My research focusses on the role of regulatory T cells in the development of atherosclerosis, and how their effects change with aging. Previous studies in mouse models have shown that regulatory T cells can reduce the formation of atherosclerotic plaques, highlighting their potential as a target for treating cardiovascular diseases. Our project, funded by the International Cardiovascular Research Partnership Awards from the British and Dutch Heart Foundations, is conducted in close collaboration with Dr. Tian Zhao's group at the University of Cambridge. The ultimate goal of the project is to uncover the full potential of regulatory T cells in the combat against atherosclerosis.